BetaEntity Annotation Prototype
← Back to treatments

Annotated abstract

Adjuvant carboplatin for high risk triple negative breast cancer

bmj · 2025-12-23 · canonical JSON source

1 visible annotations · policy: published · automated confidence ≥ 75.00%

Document resource

A potential option for patients who do not have access to neoadjuvant immunotherapy